diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
First, definition: how to judge asthenospermia in medicine?
In male fertility assessment, "asthenospermia" is not a subjective judgment, but a medical conclusion based on standardized test data.
According to the Laboratory Manual for Human Semen Examination and Processing (5th edition and subsequent updates) issued by the World Health Organization, sperm motility (that is, the proportion of sperm in forward movement) is one of the core indicators.
Common clinical standards are:
The proportion of forward moving sperm (PR) is less than 32%
Or the proportion of total exercise sperm is less than 40%
When the index is below the above range, it is usually classified as "Asthenozoospermia".
From the first-principles point of view, sperm vitality essentially represents "the ability of sperm to reach the egg".
Even if the number of sperm is normal, but the exercise ability is insufficient, the fertilization probability will be significantly reduced.
Clinical consensus: asthenospermia ≠ complete infertility, but the probability of natural conception is reduced.
Expert tip:
"There are fluctuations in semen indicators, and a single abnormality cannot be directly diagnosed. Usually, it is necessary to review 2-3 times every 2-3 weeks and then make a comprehensive judgment."

Second, the process: how to evaluate the tulip international reproductive center in Kyrgyzstan?
Judging from the actual medical treatment path, the judgment of weak sperm is not a single step, but a continuous evaluation process.
1. Preliminary assessment (remote or initial diagnosis)
Medical history collection (living habits, past diseases, pregnancy preparation time)
Analysis of previous semen reports
2. Standardized semen testing
Samples were taken after abstinence for 2–7 days.
Test items include:
Sperm concentration
Vigor (PR, NP)
form
3. In-depth evaluation (if necessary)
Sperm DNA fragmentation rate (DFI)
Hormone levels (FSH, LH, testosterone)
Testicular color Doppler ultrasound
4. Typing judgment
According to the results, asthenospermia is usually further divided into:
Mild (near critical value)
Moderate (significantly decreased)
Severe (almost no sperm moving forward)
This classification directly affects the follow-up treatment path.
The data show that abnormal sperm motility accounts for about 30%-40% of male infertility factors (source: WHO male fertility research data summary).
Third, technology: What is the mainstream treatment path for asthenospermia?
In clinical practice, the treatment of asthenospermia is not a single scheme, but a layered intervention.
Basic conditioning and intervention
Suitable for mild or reversible asthenospermia
Common measures include:
Antioxidant therapy (such as coenzyme Q10, vitamin E, etc.)
Improve lifestyle (quit smoking, control weight)
Avoid high temperature environment (such as sauna and sedentary)
Studies have shown that oxidative stress is one of the important factors affecting sperm motility (source: Andrology journal review).
2. Optimized sperm processing technology
Before entering assisted reproduction, laboratory screening is usually carried out:
density gradient centrifugation
Upstream screening
Objective: To screen sperm with stronger motility and improve the fertilization probability.
3. ICSI single sperm injection technology
When sperm motility is obviously decreased, single sperm microinjection technique is often used in clinic.
Its core logic is:
Bypass the process of "sperm swimming by itself" and complete fertilization directly.
Applicable situation:
Moderate and severe asthenospermia
Sperm quantity and motility are abnormal at the same time.
The data shows that the application ratio of ICSI technology in male factor infertility is increasing year by year (source: ESHRE European Society of Human Reproduction and Embryology report).
4. Auxiliary strategy for embryo screening (according to indications)
In some cases, it will be combined with embryonic genetic testing.
Expert tip:
"Embryo screening is mainly used for risk assessment of chromosomal abnormalities, not for asthenospermia itself, and should be selected strictly according to medical indications."
Fourth, the crowd: who needs to pay more attention to the problem of weak sperm?
From the clinical experience, the following people are more prone to sperm motility decline:
1. Long-term pregnancy unsuccessful population
Try to conceive naturally for more than one year without success.
2. People with lifestyle risk factors
Smoking and drinking
Stay up late for a long time
Working at high temperature or sedentary.
3. Those with a history of reproductive system diseases.
pampinocele
prostatitis
4. Population with increasing age
Although the decline rate of male fertility is slower than that of female, research shows that:
The rate of sperm DNA damage in men over 40 years old has increased significantly (source: Fertility and Sterility journal).
V. Q&A: Analysis of the core questions about weak sperm.
Q1: Can weak sperm get pregnant naturally?
Yes, but the probability is reduced.
Mild asthenospermia still has the chance of natural pregnancy under the condition of precise sexual intercourse during ovulation.
Q2: Do weak sperm have to be a test tube?
Not necessarily.
Depends on:
Sperm motility
Female age and ovarian reserve
Pregnancy preparation time
Q3: How long can conditioning be improved?
It is generally recommended that 3 months be a cycle (the spermatogenesis cycle is about 74 days).
But there are individual differences in the effect.
Q4: Does asthenospermia affect embryo quality?
It may be related, but it is not absolute.
Key influencing factors include:
DNA fragmentation rate
Sperm morphology
Q5: Is overseas assisted reproduction more suitable for asthenospermia?
Essentially, it depends on the technical adaptability, not the region itself.
For example, ICSI technology is mature in the world.
VI. Summary
Around [How to judge and treat asthenospermia symptoms by Tulip International Reproductive Center in Kyrgyzstan], a clear logical chain can be extracted:
1. The core of judgment: based on standardized semen analysis, not subjective feelings.
2. Decision-making key: light and heavy classification determines the path.
3. Treatment strategy: from conditioning to laboratory screening to ICSI escalation.
4. Individual differences: Different groups of people need differentiated programs.
From the perspective of holistic medicine, asthenospermia is not a single disease, but the result of multiple factors.
Summary box:
"The essence of asthenospermia is' functional decline' rather than' ability disappearance'. Scientific evaluation and layered intervention are the key paths to improve fertility opportunities."
🏥 Located in downtown Bishkek, the capital of Kyrgyzstan, near the National Museum and Victory Square. It is the first Chinese-invested, officially licensed assisted reproductive hospital in the country. Founded and directly operated by Mr. Chen Yinuo (EnoChan), the center specializes in high-level fertility services including PGT (3rd generation IVF) and legal third-party reproduction for global clients, especially Chinese patients.
🌷 Technology-Assisted Fertility, Fulfilling Dreams · Patience · Integrity · Professionalism

